3 completed, 1 active not recruiting. 4 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 3, Active not recruiting 1 |
Follow Simulect: new trials by email Literature Review of Simulect trials Research Report on Simulect
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| 90Y-DOTA-anti-CD25 Basiliximab, Fludarabine, Melphalan, and Total Marrow and Lymphoid Irradiation for the Treatment of High-Risk Acute Leukemia or Myelodysplastic Syndrome Allogeneic Hematopoietic Stem Cell Transplantation, Basiliximab, Fludarabine Phosphate - Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia | Phase 1 | Active not recruiting | City of Hope Medical Center | 7 | 2022-07-19 | 2026-07-06 |
| Radiolabeled Monoclonal Antibody Therapy and Combination Chemotherapy Before Stem Cell Transplant in Treating Patients With Primary Refractory or Relapsed Hodgkin Lymphoma basiliximab, carmustine, etoposide - Recurrent Adult Hodgkin Lymphoma | Phase 1 | Completed | City of Hope Medical Center | 25 | 2013-02-13 | 2026-10-15 |
| Vaccine Therapy and Basiliximab in Treating Patients With Acute Myeloid Leukemia in Complete Remission basiliximab, WT1 126-134 peptide vaccine, Montanide ISA 51 VG - Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities | Phase 1 | Completed | University of Chicago | 7 | 2011-12-05 | 2018-03-09 |
| Stem Cell Transplantation for Patients With Multiple Myeloma G-CSF, Plerixafor, Apheresis - Myeloma | Phase 1 | Completed | University of Chicago | 30 | 2011-07-12 | 2025-11-05 |
Congenital Abnormalities (1) · Hodgkin Disease (1) · Leukemia, Myeloid, Acute (1) · Myelodysplastic Syndromes (1) · Neoplasms, Plasma Cell (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)
City of Hope Medical Center (2) · University of Chicago (2)
United States (4)
Eileen Smith (1) · Hongtao Liu (1) · Jeffrey Y Wong (1) · Michael Bishop, MD (1)
PMID 29344432, PMID 31940591, PMID 34638132
P01CA030206 (1), P30CA033572 (1), R21CA185875 (1)